August 13, 2018
Incorporates Cygnus Technologies’ gold standard reagents Ready-to-use immunoassay kit designed to increase productivity Uppsala, Sweden. Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, today introduced Gyrolab® CHO-HCP E3G Kit for impurity analysis in the CMC (chemistry manufacturing and controls) – bioprocess workflow of biotherapeutics. The new [...]
Sphere Fluidics appoints Dr Tris Vaughan as scientific advisor
August 13, 2018
Cambridge, UK: Sphere Fluidics, a company providing single cell analysis systems underpinned by its patented picodroplet technology, announced today thatTris Vaughan, PhD FRSB has joined its scientific advisory board (SAB). Dr Vaughan’s appointment will further strengthen the company’s understanding of biopharmaceutical discovery and cell line development and help translate its technology to an industrial context. Sphere Fluidics develops [...]
EB Pure Agarose Gel Extraction Kit Offers Rapid Recovery of Fine Molecules
August 13, 2018
Empirical Bioscience announced today that they have introduced the EB Pure Agarose Gel Extraction Kit. The set is designed to quickly isolate small DNA fragments (70 bp to 20 kb) from Agarose Gel in just 15 minutes. The system’s high-binding configuration specifically, but reversibly, binds DNA or RNA under optimized conditions allowing proteins and other [...]
YMC To Acquire LEWA-Nikkiso America, Inc. Pharmaceutical Systems’ Business
August 11, 2018
LEWA remains key supply partner while YMC gains advanced downstream processing technologies and manufacturing site in North America. YMC to acquire pharmaceutical systems’ business from LEWA-Nikkiso group YMC Co., Ltd., a leading supplier of separations resins, services and systems for the pharmaceutical market, announced recently that they entered a formal agreement to acquire the pharmaceutical [...]
Anton Parr: Successfully certified
August 10, 2018
Certifications are essential in international business. "Worldwide, and especially in Asia, customers are more and more looking for companies with comprehensive certifications," explains Elisabeth Hofstätter-Kollarich, head of Quality & Management Systems at Anton Paar. Our company has been ISO 9001 certified for a long time, which confirms our high standards for the quality of our [...]
After More Than Four Decades at Merck: Walter Galinat to Retire
August 9, 2018
The Personnel Committee of the Board of Partners of E. Merck KG has resolved by best mutual agreement with Walter Galinat (62) to end his contract as a general partner of E. Merck KG and Executive Board ... DARMSTADT, GERMANY Darmstadt, Germany – The Personnel Committee of the Board of Partners of E. Merck KG [...]
MTS ANNOUNCES APPOINTMENT OF TODD KLEMMENSEN AS SENIOR VICE PRESIDENT AND GENERAL COUNSEL
August 8, 2018
Eden Prairie, Minn. – MTS Systems Corporation (NASDAQ: MTSC), a leading global supplier of high-performance test systems and sensors, today announced the appointment of Todd Klemmensen, currently MTS Systems Associate General Counsel and acting General Counsel, as Senior Vice President, General Counsel and Secretary for the company, effective August 5, 2018. Todd has over 19 years [...]
BC Platforms and Negen Announce Partnership for Early Risk Assessment of Common Diseases
August 8, 2018
Supporting personalized treatment options and providing tools to reduce healthcare expenditures BC Platforms, a world leader in genomic data management and analytics, today announces that it has signed a co-operation agreement with Negen to use its platform to provide detailed insights into raw genomic data for clinical reporting capabilities. Both companies work in the front line of [...]
Genome Editing Biotech Company EdiGene Raises $15 Million in Series pre-B Financing
August 8, 2018
BEIJING & CAMBRIDGE, Mass.--EdiGene Inc., which develops genome editing technologies into novel therapeutics for a broad range of diseases and into creative solutions to advance drug discovery, today announced the successful completion of approximately $15 Million in a Series pre-B financing. The financing is led by new investor Lilly Asia Ventures (LAV). New investor Huagai [...]
Agilent Announces Update on PD-L1 CE-IVD in Urothelial Carcinoma
August 8, 2018
PD-L1 IHC 22C3 pharmDx Can Now Be Used as an Aid to Identify Urothelial Carcinoma Patients for Treatment With KEYTRUDA® (pembrolizumab) SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that its PD-L1 IHC 22C3 pharmDx assay is now labeled for an updated use in urothelial carcinoma in Europe. Physicians in Europe can now use [...]
